| PERIOD ENDING | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | 31-Oct-08 | | Total Revenue | 14,207 | 15,343 | 14,958 | 18,426 | | Cost of Revenue | 9,725 | 9,620 | 10,170 | 11,537 | | | Gross Profit | 4,483 | 5,723 | 4,788 | 6,889 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 5,387 | 5,812 | 5,811 | 6,139 | | Non Recurring | (106) | (220) | (162) |
-
| | Others | 208 | 209 | 210 | 308 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,006) | (77) | (1,070) | 441 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1 | 2 | 33 | (270) | | Earnings Before Interest And Taxes | (1,004) | (75) | (1,037) | 172 | | Interest Expense | 171 | 168 | 174 | 150 | | Income Before Tax | (1,176) | (244) | (1,212) | 21 | | Income Tax Expense | (68) | (260) | (469) | 32 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,108) | 16 | (742) | (10) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,108) | 16 | (742) | (10) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,108) | $16 | ($742) | ($10) |
|
0.26% Nasdaq 0.00%
Income Statement
